Health and Healthcare

Abbott Laboratories : ABT

All Abbott Laboratories Articles

311 Articles

Lee Jackson | Oct 23, 2014 at 9:15 AM EDT

Companies That Benefit as Sexually Transmitted Disease Cases Keep Growing

The following companies were featured in a new Leerink report on understand testing trends for sexually transmitted diseases.

Lee Jackson | Oct 20, 2014 at 9:21 AM EDT

Jefferies Has 5 Stocks to Buy With Big Catalysts This Week

Here are five stocks that Jefferies highlights in its research report that have catalysts that could be important this week.

Jon C. Ogg | Sep 23, 2014 at 1:30 PM EDT

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have…

Paul Ausick | Jul 14, 2014 at 10:40 AM EDT

Abbott, Mylan Join Forces to Dodge U.S. Taxes

Add one more to the litany of pharmaceutical company mergers that are being made to avoid U.S. taxes. Mylan's existing…

247sarah | Jun 4, 2014 at 10:30 AM EDT

Pentagon Awards $10.5 Billion in Defense Contracts

The Department of Defense awarded $10.46 billion in defense contracts Tuesday. The winning defense contractors included included Olin Corp., Boeing,…

Jon C. Ogg | May 19, 2014 at 8:10 AM EDT

Top Analyst Upgrades and Downgrades: Altria, CenturyLink, Micron, GoGo, AT&T and More

These are the top Wall Street analyst upgrades, downgrades and initiations seen on Monday, May 19, 2014. They include Altria,…

Paul Ausick | May 5, 2014 at 11:20 AM EDT

Why Target Shares Fell Rather Than Rose on CEO Firing

Shares of Target took a hit of around 3% Monday morning following the resignation/firing of CEO Gregg Steinhafel. The interim…

Trey Thoelcke | Apr 29, 2014 at 9:25 AM EDT

Five Top Health Care Names From RBC to Buy Now

ThinkstockThe intense analysis of quantitative managers may seem like drudgery, but it can turn up absolute gems for investors looking…

Jon C. Ogg | Mar 27, 2014 at 9:15 AM EDT

Baxter Split-Up, a Page From Abbott’s Playbook

Baxter International is taking an activist investor role of its own. The health care company has announced that it is…

Jon C. Ogg | Jan 24, 2014 at 8:55 AM EST

Jefferies Highest Conviction Franchise Picks for Big Upside in 2014

The Jefferies "Franchise" stock picks for 2014 are an eclectic group that may offer investors some ideas that are not…

Jon C. Ogg | Jan 6, 2014 at 8:45 AM EST

Top Analyst Upgrades and Stocks to Buy: AIG, Genworth, SolarCity and More

These are the top analyst upgrades, initiations and positive analyst research calls seen from Wall Street on Monday, January 6.

Lee Jackson | Nov 20, 2013 at 8:30 AM EST

Top Oppenheimer Health Care Stocks to Buy for 2014

ThinkstockHealth care has been a top sector for investors this year. The research team at Oppenheimer continues to believe that…

Jon C. Ogg | Oct 2, 2013 at 12:25 PM EDT

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

ThinkstockWhen the markets go through periods of great gains, it is not uncommon to see companies start to take more…

Lee Jackson | Sep 25, 2013 at 9:00 AM EDT

Jefferies Top Stocks to Buy Based on Significant Margin Expansion

Courtesy of Abbott LaboratoriesWith many of the companies in the S&P 500 having margins approaching all-time highs, and implied S&P…

Trey Thoelcke | Jul 25, 2013 at 8:40 AM EDT

UBS New Equity Focus List Features Stocks Designed to Outperform the Market

Frank Golhen, via Wikimedia CommonsWith the equity markets seemingly hitting new all-time highs every day, we were intrigued by the…

1 … 9 10 11 12 13 … 21

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Companies That Benefit as Sexually Transmitted Disease Cases Keep Growing

Jefferies Has 5 Stocks to Buy With Big Catalysts This Week

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

Abbott, Mylan Join Forces to Dodge U.S. Taxes

Pentagon Awards $10.5 Billion in Defense Contracts

Top Analyst Upgrades and Downgrades: Altria, CenturyLink, Micron, GoGo, AT&T and More

Why Target Shares Fell Rather Than Rose on CEO Firing

Five Top Health Care Names From RBC to Buy Now

Baxter Split-Up, a Page From Abbott’s Playbook

Jefferies Highest Conviction Franchise Picks for Big Upside in 2014

Top Analyst Upgrades and Stocks to Buy: AIG, Genworth, SolarCity and More

Top Oppenheimer Health Care Stocks to Buy for 2014

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

Jefferies Top Stocks to Buy Based on Significant Margin Expansion

UBS New Equity Focus List Features Stocks Designed to Outperform the Market

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Companies That Benefit as Sexually Transmitted Disease Cases Keep Growing

Jefferies Has 5 Stocks to Buy With Big Catalysts This Week

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

Abbott, Mylan Join Forces to Dodge U.S. Taxes

Pentagon Awards $10.5 Billion in Defense Contracts

Top Analyst Upgrades and Downgrades: Altria, CenturyLink, Micron, GoGo, AT&T and More

Why Target Shares Fell Rather Than Rose on CEO Firing

Five Top Health Care Names From RBC to Buy Now

Baxter Split-Up, a Page From Abbott’s Playbook

Jefferies Highest Conviction Franchise Picks for Big Upside in 2014

Top Analyst Upgrades and Stocks to Buy: AIG, Genworth, SolarCity and More

Top Oppenheimer Health Care Stocks to Buy for 2014

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

Jefferies Top Stocks to Buy Based on Significant Margin Expansion

UBS New Equity Focus List Features Stocks Designed to Outperform the Market

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not